Tvardi Therapeutics (TVRD) Free Cash Flow: 2013-2017
Historic Free Cash Flow for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2017 value amounting to -$11.4 million.
- Tvardi Therapeutics' Free Cash Flow rose 13.91% to -$11.4 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$54.9 million, marking a year-over-year decrease of 14.11%. This contributed to the annual value of -$62.0 million for FY2024, which is 34.40% up from last year.
- Tvardi Therapeutics' Free Cash Flow amounted to -$11.4 million in Q4 2017, which was down 15.53% from -$9.9 million recorded in Q3 2017.
- Over the past 5 years, Tvardi Therapeutics' Free Cash Flow peaked at $13.2 million during Q2 2013, and registered a low of -$21.6 million during Q1 2017.
- For the 3-year period, Tvardi Therapeutics' Free Cash Flow averaged around -$10.4 million, with its median value being -$10.6 million (2017).
- As far as peak fluctuations go, Tvardi Therapeutics' Free Cash Flow increased by 28.50% in 2015, and later tumbled by 217.53% in 2016.
- Tvardi Therapeutics' Free Cash Flow (Quarterly) stood at -$5.1 million in 2013, then fell by 15.28% to -$5.8 million in 2014, then rose by 28.50% to -$4.2 million in 2015, then slumped by 217.53% to -$13.3 million in 2016, then increased by 13.91% to -$11.4 million in 2017.
- Its last three reported values are -$11.4 million in Q4 2017, -$9.9 million for Q3 2017, and -$11.9 million during Q2 2017.